Investigational Medication: Dasotraline (SEP-225,289) Background: Developed as an antidepressant medication by Sepracor. Now being studied in Attention deficit Hyperactivity Disorder by Sunovian.( Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.) Dasotraline has not been approved by the U.S. Food and Drug Administration (FDA) for the treatment of ADHD or any [...]
